How does chemotherapy for Multiple Myeloma affect my immune system

How Chemotherapy Affects Your Immune System in Multiple Myeloma

This is an important question, because understanding how treatment impacts your immune system helps you manage side effects and stay healthy during therapy.

The Dual Challenge: Cancer Cells vs. Healthy Cells

Chemotherapy drugs work by targeting fast-growing cells—which includes both myeloma cancer cells AND some of your healthy cells. According to the NCCN Guidelines for Patients: Multiple Myeloma, chemotherapy is a "systemic (whole-body) therapy that kills fast-growing cells throughout the body."

Here's the problem: Your bone marrow—where myeloma cells live—is also where your immune system cells are made. This creates a challenging situation:

What happens:

• Chemotherapy damages bone marrow cells that produce white blood cells, red blood cells, and platelets
• This leads to low blood cell counts (a condition called myelosuppression)
• With fewer white blood cells, your immune system becomes weakened

How This Affects Your Infection Risk

According to NCCN guidelines, common side effects of chemotherapy include low blood cell counts. Specifically:

• Low white blood cell count = increased risk of infections (your body's defense system is understaffed)
• Low red blood cell count = anemia (fatigue, weakness)
• Low platelet count = increased bruising and bleeding risk

The timing matters too. Your immune system is typically at its weakest about 7-14 days after each chemotherapy cycle, when blood counts reach their lowest point (called the "nadir").

Why This Matters for Your Myeloma Treatment

This is particularly relevant because multiple myeloma already weakens your immune system. According to NCCN educational materials, myeloma reduces "the number of healthy white blood cells in the body, which can increase the risk of infections." Adding chemotherapy on top of this creates a compounded effect.

What You Should Know About Your Specific Situation

The impact on your immune system depends on several factors:

• Which chemotherapy drugs you're receiving (different drugs have different effects)
• The dose and schedule of your treatment
• Your baseline health before starting treatment
• Whether you're receiving supportive care to help manage immune effects

Important Questions to Ask Your Oncology Team

Since your specific treatment plan will determine the actual impact, ask your care team:

1. Which chemotherapy drugs am I receiving, and how do they specifically affect white blood cell counts?
2. What are the expected timing and severity of my low blood cell counts during treatment?
3. What signs of infection should I watch for, and when should I call you?
4. Will I receive growth factors or other medications to help my bone marrow recover between cycles?
5. What precautions should I take during periods when my immune system is weakest?
6. Are there any activities, foods, or exposures I should avoid during treatment?

Supportive Care Is Key

The good news: Your care team has strategies to help. According to NCCN guidelines, supportive care is an important part of myeloma treatment. This may include medications to help your bone marrow recover faster and prevent infections.

Your oncologist will monitor your blood counts closely with regular blood tests (CBC—complete blood count) to track how your immune system is recovering between treatment cycles.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.